Importance of Ets1 proto-oncogene for breast cancer progression

Zentralblatt fur Gynakologie

Volumn 126, Issue 4, 2004, Pages 269-271

  Dittmer, Jürgen ^a   Vetter, M ^a   Blumenthal, S G ^b   Lindemann, R K ^c   Kolbl H ^d  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Ets proteins; PKC; Proteases

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RNA; STROMELYSIN; TRANSCRIPTION FACTOR ETS 1; UROKINASE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; DNA BINDING; DNA MICROARRAY; ENZYME DEGRADATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTO ONCOGENE; REGULATOR GENE; RNA INTERFERENCE;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HUMANS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENES; TRANSCRIPTION FACTORS;

EID: 4444303045     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822758     Document Type: Article

References (20)

1. Sharrocks AD, Brown AL, Ling Y, Yates PR. The ETS-domain transcription factor family. Int J Biochem Cell Biol 1997; 29: 1371-1387
2. Sementchenko VI, Watson DK. Ets target genes: past, present and future. Oncogene 2000; 19: 6533-6548
3. Dittmer J, Nordheim A. Ets transcription factors and human disease. Biochim Biophys Acta 1998; 1377: F1-F11
4. Dittmer J. The Biology of the Ets1 Proto-Oncogene. Mol Cancer 2003; 2: 29
5. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV, Sweep CG. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 2002; 21: 8506-8509
6. Lelievre E, Lionneton F, Soncin F, Vandenbunder B. The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol 2001; 33: 391-407
7. Fujimoto J, Aoki I, Toyoki H, Khatun S, Tamaya T. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Ann Oncol 2002; 13: 1598-1604
8. Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I. Expression of c-Ets1 is associated with malignant potential in endometrial carcinoma. Cancer 2000; 89: 2059-2067
9. Majerus MA, Bibollet-Ruche F, Telliez JB, Wasylyk B, Bailleul B. Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter. Nucleic Acids Res 1992; 20: 2699-2703
10. Ron D, Kazanietz MG. New insights into the regulation of protein kinase C and novel phorbol ester receptors. Faseb J 1999; 13: 1658-1676
11. Buchner K. The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J Cancer Res Clin Oncol 2000; 126: 1-11
12. Lindemann RK, Braig M, Ballschmieter P, Guise TA, Nordheim A, Dittmer J. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells. Int J Oncol 2003; 22: 799-805
13. Platet N, Prevostel C, Derocq D, Joubert D, Rochefort H, Garcia M. Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer 1998; 75: 750-756
14. Lindemann RK, Ballschmieter P, Nordheim A, Dittmer J. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J Biol Chem 2001; 276: 46661-46670
15. Soh JW, Lee EH, Prywes R, Weinstein IB. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 1999; 19: 1313-1324
16. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 1996; 16: 538-547
17. Ballschmieter P, Braig M, Lindemann RK, Nordheim A, Dittmer J. Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells. Int J Oncol 2003; 22: 849-853
18. Orlandi L, Binda M, Folini M, Bearzatto A, Villa R, Daidone MG, Zaffaroni N. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis. Prostate 2003; 54: 133-143
19. Gill PK, Gescher A, Gant TW. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta. Eur J Biochem 2001; 268: 4151-4157
20. Roychowdhury D, Lahn M. Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer. Semin Oncol 2003; 30: 30-33